CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea
· Delayed Price · Currency is KRW 2,880.00
-35.00 (-1.20%)
At close: Mar 21, 2025, 3:30 PM KST
KOSDAQ:261780 Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 10,092 | 5,906 | 2,386 | 3,955 | 11,838 | Upgrade
|
| Short-Term Investments | 22,550 | 32,990 | 55,377 | 47,500 | 3,000 | Upgrade
|
| Trading Asset Securities | 7,465 | - | - | 10,095 | 9,989 | Upgrade
|
| Cash & Short-Term Investments | 40,107 | 38,896 | 57,763 | 61,550 | 24,827 | Upgrade
|
| Cash Growth | 3.11% | -32.66% | -6.15% | 147.92% | 179.65% | Upgrade
|
| Accounts Receivable | -0 | 0 | -0 | -0 | -0 | Upgrade
|
| Other Receivables | 399.87 | 453.87 | 607.81 | 266.9 | 188.2 | Upgrade
|
| Receivables | 399.87 | 453.87 | 607.8 | 266.9 | 188.2 | Upgrade
|
| Prepaid Expenses | 106.63 | 94.23 | 117.1 | 12.94 | 8.52 | Upgrade
|
| Other Current Assets | 3,977 | 3,042 | 429 | 17.07 | 13.91 | Upgrade
|
| Total Current Assets | 44,590 | 42,486 | 58,917 | 61,847 | 25,037 | Upgrade
|
| Property, Plant & Equipment | 1,120 | 1,644 | 1,543 | 1,032 | 586.81 | Upgrade
|
| Long-Term Investments | 1,069 | 674.6 | 440 | 2,300 | - | Upgrade
|
| Other Intangible Assets | 174.67 | 43.58 | 39.91 | 21.77 | 28.86 | Upgrade
|
| Long-Term Accounts Receivable | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | 294.39 | 270.9 | 129.08 | 112.5 | 94.43 | Upgrade
|
| Total Assets | 47,248 | 45,119 | 61,069 | 65,313 | 25,747 | Upgrade
|
| Accrued Expenses | 129.31 | 146.74 | 77.43 | 60.77 | 63 | Upgrade
|
| Short-Term Debt | 4,950 | - | 23,240 | 20,717 | - | Upgrade
|
| Current Portion of Leases | 8.35 | 162.92 | 381.21 | 112.8 | 101.77 | Upgrade
|
| Other Current Liabilities | 4,526 | 500.53 | 3,090 | 3,816 | 4,641 | Upgrade
|
| Total Current Liabilities | 9,613 | 810.18 | 26,789 | 24,706 | 4,806 | Upgrade
|
| Long-Term Debt | 4,627 | 3,975 | - | - | 18,610 | Upgrade
|
| Long-Term Leases | 3.81 | 188.65 | 16.53 | 16.14 | 128.94 | Upgrade
|
| Other Long-Term Liabilities | 3,662 | 3,525 | 15.09 | 237.52 | 186.68 | Upgrade
|
| Total Liabilities | 19,526 | 9,702 | 27,703 | 25,698 | 24,174 | Upgrade
|
| Common Stock | 13,412 | 13,366 | 13,215 | 13,215 | 11,194 | Upgrade
|
| Additional Paid-In Capital | 79,687 | 76,782 | 72,576 | 72,576 | 18,404 | Upgrade
|
| Retained Earnings | -65,920 | -55,457 | -53,615 | -46,921 | -28,335 | Upgrade
|
| Comprehensive Income & Other | 542.97 | 725.68 | 1,190 | 745.6 | 310.07 | Upgrade
|
| Shareholders' Equity | 27,722 | 35,417 | 33,366 | 39,615 | 1,573 | Upgrade
|
| Total Liabilities & Equity | 47,248 | 45,119 | 61,069 | 65,313 | 25,747 | Upgrade
|
| Total Debt | 9,589 | 4,327 | 23,638 | 20,846 | 18,840 | Upgrade
|
| Net Cash (Debt) | 30,518 | 34,569 | 34,125 | 40,704 | 5,986 | Upgrade
|
| Net Cash Growth | -11.72% | 1.30% | -16.16% | 579.94% | 64.00% | Upgrade
|
| Net Cash Per Share | 1137.84 | 1304.13 | 1290.78 | 1745.71 | 333.84 | Upgrade
|
| Filing Date Shares Outstanding | 26.91 | 26.73 | 26.43 | 26.43 | 17.93 | Upgrade
|
| Total Common Shares Outstanding | 26.91 | 26.73 | 26.43 | 26.43 | 17.93 | Upgrade
|
| Working Capital | 34,977 | 41,676 | 32,128 | 37,141 | 20,231 | Upgrade
|
| Book Value Per Share | 1030.17 | 1324.89 | 1262.45 | 1498.91 | 87.72 | Upgrade
|
| Tangible Book Value | 27,548 | 35,373 | 33,326 | 39,593 | 1,544 | Upgrade
|
| Tangible Book Value Per Share | 1023.68 | 1323.26 | 1260.94 | 1498.09 | 86.11 | Upgrade
|
| Land | 95.09 | 95.09 | 95.09 | 95.09 | 95.09 | Upgrade
|
| Buildings | 402.68 | 402.68 | 402.68 | 402.68 | 402.68 | Upgrade
|
| Machinery | 2,086 | 1,933 | 1,622 | 1,079 | 410.3 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.